Status:
COMPLETED
Clinical Outcomes of Patients With Deferred Revascularization Based on FFR and iFR Negative Coronary Artery Lesions.
Lead Sponsor:
Aga Khan University Hospital, Pakistan
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
Brief Summary
The objective is to assess long-term clinical outcomes of patients in whom intervention of coronary lesions was deferred due to negative fractional flow reserve (FFR) and negative Instantaneous wave-f...
Detailed Description
Fractional flow Reserve (FFR) evaluates functional significance of stenosis in intermediate coronary lesions. Instantaneous wave-free ratio (iFR) is considered noninferior to FFR and does not require ...
Eligibility Criteria
Inclusion
- Patients who had intermediate to severe coronary lesions on coronary angiogram.
- Patients who had negative FFR \>0.80 or iFR \>0.89 and did not undergo immediate or planned revascularization on basis of negative physiologic assessment.
Exclusion
- Patients younger than 18 years of age or those having positive FFR/iFR values irrespective of revascularization status were excluded.
- Similarly, those who were lost to follow up and could not be traced via telephonic or were also excluded.
Key Trial Info
Start Date :
January 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2021
Estimated Enrollment :
345 Patients enrolled
Trial Details
Trial ID
NCT05240768
Start Date
January 10 2020
End Date
August 20 2021
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aga Khan University Hospital
Karachi, Sindh, Pakistan